Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1701
-
1702
The correlation of the mitochondrial dynamics–related genes with Klf5 in mouse VSMCs.
Published 2020Subjects: -
1703
-
1704
-
1705
-
1706
-
1707
Example of K<sup>trans</sup> decrease during therapy.
Published 2022“…<p>NSCLC of the left upper lobe showing a clear decrease of K<sup>trans</sup> from baseline (left) to first follow-up after 1 week of checkpoint inhibition by Erlotinib and Bevacizumab.…”
-
1708
-
1709
-
1710
-
1711
-
1712
-
1713
Supplementary Material for: Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema
Published 2021“…We aimed to investigate the effects of a systematic intervention for HAE patients. <b><i>Methods:</i></b> Thirty-three patients with HAE with C1-inhibitor deficiency, belonging to a single family, participated in a management program coordinated by an allergist/immunologist. …”
-
1714
-
1715
-
1716
-
1717
Possible Points of Canonical Wnt Inhibition.
Published 2015“…<p>This study has highlighted six possible points of canonical Wnt inhibition occurring in HSCs. (1) Predominantly non-canonical ligand expression. …”
-
1718
Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx
Published 2022“…The cancer risk showed a tendency to decrease rapidly when LTRAs were used in high dose (aHR = 0.56, 95% CI = 0.40–0.79) or for longer durations of more than 3 years (aHR = 0.68, 95% CI = 0.60–0.76) and 5 years (aHR = 0.33, 95% CI = 0.26–0.42). …”
-
1719
-
1720